Adaptimmune Therapeutics
ADAP
#9421
Rank
โ‚น4.97 B
Marketcap
โ‚น19.32
Share price
-12.60%
Change (1 day)
-82.94%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น13.07 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has โ‚น13.07 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น12.23 B-27.75%
2022-12-31โ‚น16.93 B-38.45%
2021-12-31โ‚น27.50 B2.15%
2020-12-31โ‚น26.92 B321.74%
2019-12-31โ‚น6.38 B-55.48%
2018-12-31โ‚น14.34 B7.86%
2017-12-31โ‚น13.29 B7.83%
2016-12-31โ‚น12.33 B
2015-06-30โ‚น18.11 B488.59%
2014-06-30โ‚น3.07 B20767.7%
2013-06-30โ‚น14.75 M-91.21%
2012-06-30โ‚น0.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น79.59 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.47 B-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.68 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น95.81 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA